|
Volumn 14, Issue 6, 2001, Pages 384-390
|
European randomised trial of dual versus triple tacrolimus-based regimens for control of acute rejection in renal allograft recipients
a a b c d e f g h |
Author keywords
Acute rejection; Immunosuppression; Kidney transplantation; Tacrolimus
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
METHYLPREDNISOLONE;
PREDNISONE;
TACROLIMUS;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
EUROPE;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
ACUTE DISEASE;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
TACROLIMUS;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0035665112
PISSN: 09340874
EISSN: None
Source Type: Journal
DOI: 10.1007/s001470100003 Document Type: Article |
Times cited : (14)
|
References (11)
|